Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mithun Raje

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|November 5, 2013
Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesisCamilo Rojas, Mithun Raje, Takashi Tsukamoto, et al.
RSC Medicinal Chemistry|April 27, 2026
Lead optimization of <b>5jc21</b> (CG13250), a quinolin-2(1<i>H</i>)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteinsJay Chauhan, Sarah Pogash, Makoto Yoshioka, et al.
The Biochemical Journal|July 4, 2012
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphateYugesh Kharel, Mithun Raje, Ming Gao, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidaseMithun Raje, Niyada Hin, Bridget Duvall, et al.
Cancer Letters|March 4, 2022
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivoYinan Wang, Chuanhe Yang, Michelle M Sims, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme functionJay Chauhan, Shen-En Chen, Katherine J Fenstermacher, et al.
Pulmonary Pharmacology & Therapeutics|August 23, 2021
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosisShunya Kaneshita, Takashi Kida, Makoto Yoshioka, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|November 5, 2013
Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesisCamilo Rojas, Mithun Raje, Takashi Tsukamoto, et al.
RSC Medicinal Chemistry|April 27, 2026
Lead optimization of <b>5jc21</b> (CG13250), a quinolin-2(1<i>H</i>)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteinsJay Chauhan, Sarah Pogash, Makoto Yoshioka, et al.
The Biochemical Journal|July 4, 2012
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphateYugesh Kharel, Mithun Raje, Ming Gao, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536Lijia Chen, Jeremy L Yap, Makoto Yoshioka, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidaseMithun Raje, Niyada Hin, Bridget Duvall, et al.
Cancer Letters|March 4, 2022
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivoYinan Wang, Chuanhe Yang, Michelle M Sims, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme functionJay Chauhan, Shen-En Chen, Katherine J Fenstermacher, et al.
Pulmonary Pharmacology & Therapeutics|August 23, 2021
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosisShunya Kaneshita, Takashi Kida, Makoto Yoshioka, et al.
Pageof 1